Adeno associated virus (AAV) mediated hepatic reconstitution of CFLAR improves glucose tolerance and alleviates liver fibrosis both in mice and monkeys, rendering it an attractive target for development of novel therapies against NASH.[209]. Here, CFLAR is linked to metabolic dysfunction-associated steatohepatitis.